Addition of Radiotherapy to the Primary Tumour in Oligometastatic NSCLC: A Systematic Review and Meta-Analysis
Advanced non-small cell lung cancer (NSCLC) remains an almost incurable disease, with prognosis significantly improved with the advent of immunotherapy that has increased overall survival (OS) in both first and subsequent lines of therapy. Recently, the availability of more focused radiation delivery in the form of stereotactic body radiation therapy (SBRT) has permitted the treatment of both primary and distant metastases in particular when oligometastatic sites of disease permit aggressive local therapy (e.g.
Source: Lung Cancer - Category: Cancer & Oncology Authors: Fausto Petrelli, Antonio Ghidini, Mary Cabiddu, Gianluca Tomasello, Agostina De Stefani, Lorenza Bruschieri, Elisabetta Vitali, Mara Ghilardi, Karen Borgonovo, Sandro Barni, Francesca Trevisan Tags: Review Source Type: research
More News: Cancer | Cancer & Oncology | Immunotherapy | Lung Cancer | Non-Small Cell Lung Cancer | Radiation Therapy